The content on this site is intended for healthcare professionals only
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
25 Sep 2019
Real-world use of carfilzomib therapy among patients with existing cardiovascula...
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
25 Sep 2019
Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma pati...
Dr Charlotte Pawlyn - Royal Marsden Hospital, London, UK
25 Sep 2019
HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients wi...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
25 Sep 2019
Iberdomide in combination with dexamethasone for multiple myeloma
Prof Sagar Lonial - Winship Cancer Institute, Atlanta, USA
25 Sep 2019
First results of the GMMG-CONCEPT trial for multiple myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
25 Sep 2019
What is the role of autologous stem cell transplant in multiple myeloma?
Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical ...
25 Sep 2019
Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multipl...
Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical ...
25 Sep 2019
PLEIADES: Daratumumab combinations for multiple myeloma
Dr Ajai Chari - Mount Sinai, New York City, USA
25 Sep 2019
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multipl...
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019
Treatment options for high risk relapsed/refractory multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019
BCMA: A new biomarker for multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
25 Sep 2019